| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.15B | 1.03B | 1.10B | 1.07B | 1.11B | 1.28B |
| Gross Profit | 601.31M | 539.75M | 595.86M | 570.65M | 597.67M | 639.24M |
| EBITDA | -491.35M | -221.10M | 393.84M | 399.35M | 393.37M | 439.54M |
| Net Income | -724.67M | -563.97M | -66.67M | 32.98M | 55.70M | 77.88M |
Balance Sheet | ||||||
| Total Assets | 19.85B | 20.11B | 20.57B | 21.41B | 21.85B | 21.29B |
| Cash, Cash Equivalents and Short-Term Investments | 911.95M | 1.11B | 1.33B | 1.88B | 2.02B | 2.02B |
| Total Debt | 7.26B | 7.57B | 7.64B | 7.25B | 6.66B | 6.47B |
| Total Liabilities | 9.15B | 9.30B | 9.23B | 9.48B | 9.24B | 9.00B |
| Stockholders Equity | 7.01B | 7.12B | 7.54B | 7.99B | 8.45B | 8.23B |
Cash Flow | ||||||
| Free Cash Flow | 61.78M | 457.70M | 57.15M | 153.57M | 265.54M | 168.02M |
| Operating Cash Flow | 61.48M | 459.32M | 62.69M | 154.84M | 267.73M | 189.22M |
| Investing Cash Flow | -65.38M | -92.20M | -544.28M | -540.08M | -218.81M | -38.40M |
| Financing Cash Flow | -165.68M | -573.56M | -9.25M | 339.57M | -158.04M | -481.67M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
54 Neutral | HK$363.90M | -0.37 | -10.26% | ― | 48.60% | -441.98% | |
46 Neutral | HK$330.00M | -59.48 | -9.32% | ― | -72.10% | 90.00% | |
44 Neutral | HK$258.00M | -1.25 | ― | ― | ― | ― | |
42 Neutral | HK$160.16M | -0.10 | -34.31% | ― | -63.41% | 77.97% | |
39 Underperform | HK$359.42M | -0.66 | -21.15% | ― | 69.55% | 64.09% | |
39 Underperform | HK$180.13M | -0.04 | 93.94% | ― | -60.50% | -103.48% |